Biological Warfare: Warnings, Clusters, Targeting and Defense
Recognition Lag in U.S. Biodefense: Why the United States Finds Out Late, and What Congress Can Do About It
- Type
- Working paper measuring how long the United States takes to recognize a new disease, why that matters for defense against biological weapons, and three changes in law that would be tested against it.
- Governing judgment
- The United States would probably not recognize a deliberate release of a pathogen that spreads between people materially faster than it recognized the seven natural or zoonotic events of the past twenty-two years, and it would probably not be able to attribute such an event to a state within the first months after recognition. The effect of the proposed measures is untested, rated roughly even with low confidence.
- Scope
- Unclassified, public sources only. The paper discusses disease at the level of populations, clinics and laboratories, and contains nothing on how an agent is made, altered or released. COVID-19 appears only as a measure of scale and delay.
- Keywords
- Biodefense; biosurveillance; attribution; Biological Weapons Convention; pathogen-agnostic sequencing; wastewater surveillance; pandemic preparedness; national security.
- JEL classification
- H56, I18, K32, H11.
- Revision history
- Version 1.0, 12 October 2026: first complete text. Version 1.1, 22 October 2026. Version 1.2, 23 October 2026. Posted on SSRN 31 October 2026. The paper’s note gives the detail of each version.
The United States does not learn that a new disease is spreading until weeks or months after the first infection. This paper measures that delay, explains why it matters for defense against biological weapons, and proposes what Congress can do. In seven outbreaks of new or newly arrived pathogens since 2002, the time from the start of spread, as estimated or first observed, to recognition ran from about seven weeks to two years, with a median of about thirteen weeks. Establishing who or what caused an outbreak takes longer: three documented deliberate or concealed biological events took from just over one year to thirteen years to resolve.
The 2026 Annual Threat Assessment reports that states with weapons programs are developing capabilities designed to defeat detection and attribution. In 2025 and 2026 the federal offices charged with integration and attribution were dismantled, emptied or left unsettled.
The paper sets out three changes in law and the measure that would test each: one accountable official who publishes three response intervals every year; permanent authority and funding for wastewater surveillance and pathogen-agnostic sequencing; and a standing attribution protocol with legal limits on the use of health data. No published evidence shows how many days these changes would save. The reporting requirement is how Congress would find out.
The United States finds out late, and no one answers for the combined result. In seven outbreaks since 2002, recognition took from about seven weeks to two years, with a median of about thirteen weeks. Establishing who or what caused an outbreak takes longer: from just over a year to thirteen years in three documented cases. No published evidence shows how many days the proposed changes would save. The reporting requirement is how Congress would find out.
What this paper does not establish
No unclassified source reports a biological campaign against the United States or its allies, and this paper assesses none. Classified collection may change the threat picture in either direction. The COVID-19 figures measure a pandemic whose origin is unresolved. They are not evidence of a deliberate release and do not forecast the scale of an attack.
The interval analysis rests on seven events chosen by a stated rule, with start dates measured in two ways and recognition points in three. The median describes these seven events and nothing more. No national series exists for the proposed measures, and no study shows that the changes would shorten recognition or attribution. The window of months for attribution is a stipulation, not a measured threshold.
Some facts on wastewater coverage and funding, staffing and the placement of BioWatch rest on press reports or advocacy letters. Budget, legislative and organizational facts are as of 23 October 2026.
Suggested citation
George, Collin B. Biological Warfare: Warnings, Clusters, Targeting and Defense: Recognition Lag in U.S. Biodefense: Why the United States Finds Out Late, and What Congress Can Do About It. Sanctir Working Paper, WP-2026 series, version 1.2, 23 October 2026. Licensed CC BY-NC-ND 4.0. SSRN 7671038.